Renal Cancer
Adjuvant treatment for renal cell carcinoma: do we finally have a major breakthrough?
December 12, 2016
MicroRNA profiling in clear cell renal cell carcinoma tissues potentially links tumorigenesis and recurrence with obesity
December 9, 2016
Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma
December 9, 2016
Genetic predisposition to kidney cancer
December 8, 2016
The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma
December 8, 2016
Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness
December 8, 2016
Partial Versus Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes
December 7, 2016
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma
December 7, 2016
Sunitinib in the treatment of metastatic renal cell carcinoma
December 6, 2016
Cabozantinib in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience
December 6, 2016
Obesity and Kidney Cancer
December 5, 2016
Excess weight as a risk factor common to many cancer sites: words of caution when interpreting meta-analytic evidence
December 5, 2016
Safety, Tolerability and Pharmacokinetics of Oral Administration of GW786034 in Patients with Solid Tumors
December 4, 2016
Patient perspectives on the barriers associated with medication adherence to oral chemotherapy
December 2, 2016
Prediction of Competing Mortality for Decision Making between Surgery or Observation in Elderly Patients with T1 Kidney Cancer
November 29, 2016
Advances in Cancer Immunotherapy in Solid Tumors
November 28, 2016